Global Thoracic Catheters Market Trends and Insights
Rising Pleural Effusion and Pneumothorax Burden
Non-malignant pleural effusion has an estimated global incidence of 252 cases per 100,000 people. It accounted for 63.5% of adult pleural disease hospitalizations in the United States and generated USD 10.1 billion in annual health care costs in the cited analysis . Japan recorded 14,719 pneumothorax procedures and 5,143 empyema procedures in its 2024 national surgical database. The same national dataset reported that 70% of spontaneous pneumothorax cases needed intervention beyond initial drainage. Cardiac, renal, and hepatic dysfunction can cause recurring effusions, and these patients had a 1-year mortality of up to 50%. This clinical burden broadens thoracic catheter market demand beyond postoperative procedures because many patients require repeated drainage during chronic care.Higher Thoracic and Cardiothoracic Surgery Volumes
Japan performed 94,961 general thoracic procedures in 2024, which was 2.2 times the volume reported in 2000. Its 2024 volume was also 9.4% above the 2020 pandemic low point, and video-assisted thoracoscopic surgery represented 90% of procedures. Germany’s registry reported 181,988 cardiac and vascular procedures across 78 departments in 2025. Baylor Scott & White reported 13% growth in thoracic procedures from fiscal 2024 to fiscal 2025, with 315 of 386 procedures performed robotically. Each procedure can require catheter placement during surgery or for postoperative drainage. The growing use of video-assisted and robotic techniques also favors smaller, less traumatic devices that work with minimally invasive recovery pathways in the Thoracic catheters market.Catheter Complications and Placement Capability
A systematic review covering 4,973 small-bore chest drain insertions reported an overall failure rate of 19.4%. Tube dislodgement occurred in 5.9% of cases, blockage in 5.4%, kinking in 3.7%, and misplacement in 3.3%. A pooled analysis of 41 studies on indwelling pleural catheters found a 20.3% overall complication rate, including a 5.7% infection rate and a 1.5% blockage rate. These events may lead to reinsertion, readmission, or surgical drainage, increasing the cost of the care episode. Training availability is especially important for ultrasound-guided placement and tunneled catheter programs, and shortages can slow adoption in settings with fewer specialists. The Thoracic catheters market will reward suppliers that pair a device with clinical education and evidence that shows dependable drainage performance.Other drivers and restraints analyzed in the detailed report include:
- Minimally Invasive Drainage, Outpatient Care, and Materials Innovation
- Digital Drainage and Enhanced Recovery Workflows
- Pricing Pressure and Single-Use Device Requirements
Segment Analysis
Pleural drainage catheters held 35.84% of 2026 product revenue, accounting for the largest product position in the Thoracic catheters market. Their use is supported by frequent treatment of malignant and non-malignant pleural effusions. Indwelling tunneled catheters also support outpatient pathways for patients who need ongoing drainage. Thoracostomy tubes remain important after cardiac surgery and in emergency care. Their larger diameter remains useful for viscous, hemorrhagic, or coagulating collections. The systematic review reported a 45.6% failure rate for small-bore drains in empyema and complicated parapneumonic effusions.Thoracostomy procedure kits and trays are forecast to grow at a 10.23% CAGR through 2032. The kits bring catheters, sterile components, and related items into a single purchasing unit. This format can standardize setup and reduce variation across inpatient and ambulatory surgical center settings. Thoracic suction catheters continue to address specialized cardiac surgery and postoperative uses. Trocar catheters are also used in palliative pleural care and have reported procedure times 5 to 8 minutes shorter than conventional large-bore intercostal drain placement and technical success above 96% in selected patients. Accessories such as connectors, water-seal chambers, and digital canisters remain important because digital platforms use dedicated single-use supplies. The Thoracic catheters industry is therefore moving from component purchasing toward a procedure-kit model that can support adoption of improved materials and coatings.
Silicone held 40.27% of 2026 material revenue, making it the largest material category. It is valued for biocompatibility, a hypoallergenic profile, and suitability for longer indwelling periods. These features matter for tunneled pleural catheters that remain in place for weeks or months. Silicone is consequently well suited to recurring effusion management and outpatient care. Its established clinical role provides a stable base for premium catheter systems. The material remains particularly relevant when patient comfort and tissue tolerance are priorities.
Polyurethane is forecast to grow at a 10.96% CAGR through 2032. The category benefits from antimicrobial coatings, multi-durometer construction, improved radiopacity, kink resistance, and thinner walls. Avient presented thermoplastic polyurethane options for health care devices in 2025, including radiopaque formulations that can support catheter development . A 2025 study found that polycaprolactone-coated polyurethane catheters loaded with ampicillin maintained antibacterial activity for 40 days and reduced bacterial counts by more than 99.9% compared with uncoated controls. PVC faces pressure from environmental concerns related to phthalate plasticizers, while latex use continues to decline because of sensitization risk and latex-free purchasing policies. Bioabsorbable materials and thermoplastic elastomers remain early-stage options for drug-eluting drainage systems in the thoracic catheters market.
Complete Report Scope:
- By Product Type
- Thoracostomy Tubes
- Pleural Drainage Catheters
- Thoracic Suction Catheters
- Trocar Catheters
- Thoracostomy Procedure Kits and Trays
- Thoracic Drainage Accessories
- By Material
- Silicone
- Polyurethane
- Polyvinyl Chloride
- Latex
- Other Advanced Polymers
- By Procedure and Access Technique
- Seldinger-Guided Small-Bore Placement
- Surgical Thoracostomy Placement
- Trocar-Assisted Placement
- Tunneled Indwelling Pleural Catheter Placement
- By Application
- Pleural Effusion
- Pneumothorax
- Hemothorax
- Empyema and Complicated Pleural Infection
- Other Indications
- By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Other End Users
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
North America held 38.24% of 2026 revenue, giving the region the largest position in the Thoracic catheters market. The region has high cardiothoracic procedure volumes, payer support for hospital and outpatient drainage, and mature interventional pulmonology services. New Jersey reported 10,931 open-heart and transcatheter aortic valve replacement procedures in 2025. Cedars-Sinai reported a 1.5-day reduction in mean hospital stay after it adopted digital chest drainage for pulmonary resection. The same program reported estimated annual savings of USD 800,000, which supports procurement decisions based on care-pathway value rather than product price alone. Provincial cancer centers in Canada are expanding outpatient tunneled catheter programs for palliative malignant pleural effusion management. Credentialing needs for ultrasound-guided and tunneled placement remain a limiting factor in some community hospitals.Asia-Pacific is forecast to grow at a 10.04% CAGR through 2032, the highest regional growth rate in the Thoracic catheters market. Japan completed 94,961 general thoracic surgeries in 2024, with video-assisted thoracoscopic surgery representing 90% of the total. This procedure base supports early use of small-bore and digital drainage solutions. China and India are building tertiary thoracic surgery capacity, which expands demand for basic kits and specialty catheters. Higher tuberculosis and parapneumonic infection burdens in parts of these countries also sustain demand for large-bore drainage. South Korea and Australia are moving toward digital drainage through enhanced recovery protocols and procurement standards that value documented patient outcomes. Japan, South Korea, and Australia are likely to favor premium systems sooner, while China and India may retain a larger acute-care large-bore mix for longer. This split requires Thoracic catheters market participants to match product portfolios to local treatment patterns and purchasing capacity.
Germany recorded 181,988 cardiac and vascular procedures in 2025, supporting continued drainage demand across its academic and community centers. The European Union Medical Device Regulation sets the compliance framework for medical devices, and its Health Technology Assessment Regulation began coordinated implementation in January 2025. These compliance factors raise evidence requirements and can lengthen entry timelines for new drainage systems. The United Kingdom, France, Italy, and Spain retain significant thoracic surgery activity, while German and United Kingdom academic programs support early use of coaxial drains and digital monitoring. Brazil and Argentina are widening thoracic care capacity, although tariff exposure and price sensitivity favor locally assembled or cost-engineered products. Gulf Cooperation Council countries with tertiary facilities import premium products, while many sub-Saharan systems primarily use standard chest tubes distributed through regional supply networks. The Thoracic catheters market size across these mixed geographies will depend on the balance between infrastructure investment, regulatory readiness, and access to trained clinical teams.
List of Companies Covered in this Report:
- Angiplast Private Limited
- Argon Medical Devices
- ATMOS MedizinTechnik
- B. Braun
- Beckton Dickinson
- Cardinal Health
- Cook Group
- Getinge
- ICU Medical
- Medela
- Medtronic
- Merit Medical Systems
- Poly Medicure
- Redax S.p.A.
- Rocket Medical plc
- Sinapi Biomedical
- Sterimed Group
- Teleflex
- Utah Medical Products
- Vygon
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Angiplast Private Limited
- Argon Medical Devices, Inc.
- ATMOS MedizinTechnik GmbH & Co. KG
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Cook Medical
- Getinge AB
- ICU Medical, Inc.
- Medela AG
- Medtronic plc
- Merit Medical Systems, Inc.
- Poly Medicure Limited
- Redax S.p.A.
- Rocket Medical plc
- Sinapi Biomedical
- Sterimed Group
- Teleflex Incorporated
- Utah Medical Products, Inc.
- Vygon SA

